• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自 1989 年以来,荷兰甲状腺癌的发病率上升,但生存率没有变化,死亡率下降。

Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989.

机构信息

Department of Medical Psychology and Neuropsychology, Center of Research on Psychology in Somatic Diseases, Tilburg University, Warandelaan 2, PO Box 90153, 5000 LE Tilburg, The Netherlands.

出版信息

Endocr Relat Cancer. 2013 Mar 26;20(2):263-71. doi: 10.1530/ERC-12-0336. Print 2013 Apr.

DOI:10.1530/ERC-12-0336
PMID:23447568
Abstract

The incidence of thyroid cancer (TC) is increasing worldwide, partly due to increased detection. We therefore assessed combined trends in incidence, survival and mortality of the various types of TC in The Netherlands between 1989 and 2009. We included all patients ≥15 years with TC, diagnosed in the period 1989-2009 and recorded in The Netherlands Cancer Registry (n=8021). Information on age, gender, date of diagnosis, histological type of tumour and tumour-node-metastasis classification was recorded. Mortality data (up to 1st January 2010) were derived from Statistics Netherlands. Annual percentages of change in incidence, mortality and relative survival were calculated. Since 1989 the incidence of TC increased significantly in The Netherlands (estimated annual percentage change (EAPC)=+1.7%). The incidence rates increased for all age groups (except for females >60 years), papillary tumours (EAPC=+3.5%), T1 and T3 TC (EAPC=+7.9 and +5.8% respectively). Incidence rates decreased for T4 TC (-2.3%) and remained stable for follicular, medullary anaplastic and T2 TC. Five-year relative survival rates remained stable for papillary (88%) and follicular (77%) TC, all age groups and T1-T3 TC (96, 94 and 80% respectively) and somewhat lower for T4 (53%), medullary (65%) and anaplastic TC (5%) in the 2004-2009 period compared with earlier periods. Mortality due to TC decreased (EAPC=-1.9%). TC detection and incidence has been rising in The Netherlands, while mortality rates are decreasing and survival rates remained stable or slightly decreasing.

摘要

甲状腺癌(TC)的发病率在全球范围内呈上升趋势,部分原因是检测的增加。因此,我们评估了 1989 年至 2009 年荷兰各种类型 TC 的发病率、生存率和死亡率的综合趋势。我们纳入了所有在 1989 年至 2009 年期间诊断为 TC 的年龄≥15 岁的患者,并记录在荷兰癌症登记处(n=8021)。记录了年龄、性别、诊断日期、肿瘤的组织学类型和肿瘤-淋巴结-转移分类。死亡率数据(截至 2010 年 1 月 1 日)来自荷兰统计局。计算了发病率、死亡率和相对生存率的年变化百分比。自 1989 年以来,荷兰 TC 的发病率显著增加(估计年变化百分比(EAPC)=+1.7%)。所有年龄组(60 岁以上女性除外)、乳头状肿瘤(EAPC=+3.5%)、T1 和 T3 TC(EAPC=+7.9%和+5.8%)的发病率均增加。T4 TC 的发病率(-2.3%)下降,滤泡性、髓样间变性和 T2 TC 的发病率保持稳定。5 年相对生存率在乳头状(88%)和滤泡性(77%)TC 以及所有年龄组和 T1-T3 TC(分别为 96%、94%和 80%)中保持稳定,而在 T4(53%)、髓样(65%)和间变性 TC(5%)中则略有下降2004-2009 年与早期相比。TC 死亡率下降(EAPC=-1.9%)。荷兰 TC 的检出率和发病率上升,而死亡率下降,生存率保持稳定或略有下降。

相似文献

1
Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989.自 1989 年以来,荷兰甲状腺癌的发病率上升,但生存率没有变化,死亡率下降。
Endocr Relat Cancer. 2013 Mar 26;20(2):263-71. doi: 10.1530/ERC-12-0336. Print 2013 Apr.
2
Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery.1989年至2003年荷兰甲状腺癌的发病率和死亡率趋势:与甲状腺细针穿刺细胞学检查及甲状腺手术的相关性
Int J Cancer. 2008 Oct 1;123(7):1681-4. doi: 10.1002/ijc.23678.
3
Changing trends in incidence and mortality of thyroid cancer in Scotland.苏格兰甲状腺癌发病率和死亡率的变化趋势
Clin Endocrinol (Oxf). 2005 Feb;62(2):156-62. doi: 10.1111/j.1365-2265.2004.02187.x.
4
[Thyroid cancer in Southeastern Netherlands, 1970-1989: trends in incidence, treatment and survival].[1970 - 1989年荷兰东南部的甲状腺癌:发病率、治疗及生存趋势]
Ned Tijdschr Geneeskd. 1994 Feb 26;138(9):464-8.
5
Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.法国甲状腺癌的描述性流行病学:发病率、死亡率和生存率。
Ann Endocrinol (Paris). 2010 Mar;71(2):95-101. doi: 10.1016/j.ando.2009.11.006. Epub 2009 Dec 29.
6
Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.荷兰皮肤鳞状细胞癌的趋势:发病率上升,但相对生存率和死亡率稳定 1989-2008。
Eur J Cancer. 2012 Sep;48(13):2046-53. doi: 10.1016/j.ejca.2012.01.003. Epub 2012 Feb 16.
7
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.86690例甲状腺癌患者的生存情况:一项基于欧洲癌症研究与治疗组织(EUROCARE)-5中29个欧洲国家人群的研究。
Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.
8
A clinical epidemiologic study of thyroid carcinoma in Malmö, Sweden.瑞典马尔默甲状腺癌的临床流行病学研究。
Curr Probl Cancer. 1984 Aug;8(14):1-49. doi: 10.1016/s0147-0272(84)80015-x.
9
Thyroid Cancer Epidemiology in South Spain: a population-based time trend study.西班牙南部的甲状腺癌流行病学:基于人群的时间趋势研究。
Endocrine. 2018 Nov;62(2):423-431. doi: 10.1007/s12020-018-1681-6. Epub 2018 Jul 24.
10
Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival.新诊断甲状腺癌患者的合并症:一项基于人群的患病率及对治疗和生存影响的研究。
Clin Endocrinol (Oxf). 2006 Apr;64(4):450-5. doi: 10.1111/j.1365-2265.2006.02492.x.

引用本文的文献

1
Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study.甲状腺癌患者生活质量和疾病特异性症状的决定因素及中介机制:WaTCh研究设计
Thyroid Res. 2023 Jul 10;16(1):23. doi: 10.1186/s13044-023-00165-5.
2
Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study.男性性别不是分化型甲状腺癌复发的独立危险因素:一项倾向评分匹配研究。
Sci Rep. 2021 Jul 21;11(1):14908. doi: 10.1038/s41598-021-94461-5.
3
Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases.
甲状腺髓样癌手术后的并发症:SQRTPA 和 EUROCRINE®数据库的多中心研究。
Br J Surg. 2021 Jun 22;108(6):691-701. doi: 10.1093/bjs/znaa195.
4
Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?男性性别是甲状腺乳头状癌的一个预后因素吗?
J Clin Med. 2021 May 31;10(11):2438. doi: 10.3390/jcm10112438.
5
Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.越南胡志明市甲状腺癌发病趋势及组织学模式(1996-2015 年):一项基于人群的研究。
BMC Cancer. 2021 Mar 20;21(1):296. doi: 10.1186/s12885-021-08023-z.
6
Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening.用于放射性碘难治性筛查的患者来源的甲状腺乳头状癌类器官
Cancers (Basel). 2020 Oct 31;12(11):3212. doi: 10.3390/cancers12113212.
7
Changes in the Demographic and Clinicopathological Characteristics of Thyroid Cancer: A Population-Based Investigation in Algeria, 1993-2013.甲状腺癌的人口统计学和临床病理特征变化:1993 - 2013年阿尔及利亚基于人群的调查
J Cancer Epidemiol. 2020 Sep 22;2020:7812791. doi: 10.1155/2020/7812791. eCollection 2020.
8
Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry.甲状腺癌亚型之间转移模式的差异源于全国荷兰病理登记处。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e299-306. doi: 10.1210/clinem/dgz078.
9
Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study.丹麦 1997-2014 年的甲状腺髓样癌的生存和长期生化治愈:一项全国性研究。
Thyroid. 2019 Mar;29(3):368-377. doi: 10.1089/thy.2018.0564. Epub 2019 Jan 31.
10
Nutritional and Environmental Factors in Thyroid Carcinogenesis.营养与环境因素与甲状腺癌发生。
Int J Environ Res Public Health. 2018 Aug 13;15(8):1735. doi: 10.3390/ijerph15081735.